RT Journal Article
SR Electronic
T1 Protocol for a cluster randomised controlled trial to evaluate the effectiveness of digital health interventions in improving non-communicable disease management during the pandemic in rural Pakistan
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.02.17.23286113
DO 10.1101/2023.02.17.23286113
A1 Wei, Xiaolin
A1 Khan, Nida
A1 Durrani, Hammad
A1 Muzaffar, Naila
A1 Haldane, Victoria
A1 Walley, John D.
A1 Thorpe, Kevin
A1 Ge, Erjia
A1 Ge, Shiliang
A1 Dodd, Warren
A1 Wallace, James
A1 Aslanyan, Garry
A1 Laporte, Audrey
A1 Khan, Muhammad Amir
YR 2023
UL http://medrxiv.org/content/early/2023/02/19/2023.02.17.23286113.abstract
AB Background The COVID-19 pandemic has revealed gaps in global health systems, especially in the low- and middle-income countries (LMICs). Evidence shows that patients with non-communicable diseases (NCDs) are at higher risk of contracting COVID-19 and suffering direct and indirect health consequences. Considering the future challenges such as environmental disasters and pandemics to the LMICs health systems, digital health interventions (DHI) are well poised to strengthen health care resilience. This study aims to implement and evaluate a comprehensive package of DHIs of integrated COVID-NCD care to manage NCDs in primary care facilities in rural Pakistan.Methods The study is designed as a pragmatic, parallel two-arm, multi-centre, cluster randomised controlled trial. We will randomise 30 primary care facilities in three districts of Punjab, where basic hypertension and diabetes diagnosis and treatment is provided, with a ratio of 1:1 between intervention and control. In each facility, we will recruit 50 patients who have uncontrolled hypertension. The intervention arm will receive training on an integrated COVID-NCD guideline, and will use a smartphone app-based telemedicine platform where patients can communicate with health providers and peer-supporters, along with a remote training and supervision system. Usual care will be provided in the control arm. Patients will be followed up for 10 months. Our primary indicator is systolic blood pressure measured at 10 months. A process evaluation guided by implementation science frameworks will be conducted to explore implementation questions. A cost-effectiveness evaluation will be conducted to inform future scale up in Pakistan and other LMICs.Discussion Our study is one of the first randomised controlled trials to evaluate the effectiveness of DHIs to manage NCDs to strengthen health system resilience in LMICs. We will also evaluate the implementation process and cost-effectiveness to inform future scale-up in similar resource constrained settings.Trial registration ClinicalTrials.gov Identifier - NCT05699369Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT05699369Funding StatementThis study is funded by the Canadian Institutes of Health Research (CIHR, https://cihr-irsc.gc.ca/). XW received this fund (grant number: EG7-179465).The funder had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The trial protocol has obtained ethical approval from the Office of Research Ethics at the University of Toronto (Ref: 42337) and the Institutional Review Board of the Association for Social Development, Pakistan (Ref: IORG0011016 dated 04 March 2022)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableNo datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.ASDAssociation of Social DevelopmentDHIDigital Health InterventionECHOExtension for Community Healthcare OutcomesRHCRural Health CentreNCDNon-Communicable DiseasesLMICsLow-and-Middle-Income CountriesTMUTrial Management UnitWDFWorld Diabetes FoundationWHOWorld Health Organisation